Hunan Warrant Pharmaceutical Co.,Ltd (SHA:688799)
China
· Delayed Price · Currency is CNY 44.73
+1.16 (2.66%)
At close: Mar 10, 2026
SHA:688799 Revenue
In the year 2025, Hunan Warrant Pharmaceutical Co.,Ltd had annual revenue of 1.52B CNY with 7.26% growth. Hunan Warrant Pharmaceutical Co.,Ltd had revenue of 429.77M in the quarter ending December 31, 2025, with 25.06% growth.
Revenue
1.52B
Revenue Growth
+7.26%
P/S Ratio
3.88
Revenue / Employee
n/a
Employees
1,234
Market Cap
5.87B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 1.52B | 102.65M | 7.26% |
| Dec 31, 2024 | 1.41B | -19.84M | -1.38% |
| Dec 31, 2023 | 1.43B | 140.13M | 10.84% |
| Dec 31, 2022 | 1.29B | 146.06M | 12.74% |
| Dec 31, 2021 | 1.15B | 195.97M | 20.61% |
| Dec 31, 2020 | Pro | Pro | Pro |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
| Dec 31, 2014 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Zhejiang Sunflower Great Health | 302.92M |
| Jiangsu Jibeier Pharmaceutical | 964.93M |
| Teyi Pharmaceutical Group Co.,Ltd | 924.04M |
| Tianjin Lisheng Pharmaceutical | 1.32B |
| Chongqing Pharscin Pharmaceutical | 786.51M |
| Shandong Sinobioway Biomedicine | 257.74M |
| Shanxi Zhendong Pharmaceutical Co.,Ltd | 2.92B |
| ChengDu ShengNuo Biotec | 741.34M |